Menu
Principal investigator: Prof. dr. P.A. (Pieter) Doevendans, Prof. dr. E. (Eva) van Rooij
Started: May 1st 2023
About the GEREMY project
The GEREMY project is funded by the European Health & Digital Executive Agency and aims to deliver the first cardiac gene therapy (GT) for treatment of rare inherited forms of arrhythmogenic cardiomyopathy (ACM), such as PLN- and PKP2-mutation induced ACM. These will serve as models for other inherited heart diseases and contribute directly to the portfolio of treatments for rare cardiac diseases.
Inherited cardiovascular conditions are a group of genetic disorders that primarily affect the heart. They include conditions such as cardiomyopathy, inherited electrical conditions called channelopathies and problems with the main blood vessel carrying blood from the heart, the aorta. They affect people of any age. If left untreated, some inherited heart conditions can be life-threatening. These inherited cardiac disorders cover a wide variety of relatively rare cardiac diseases, for which we don’t have any effective treatment or cure available. The GEREMY project would like to change that, and thus is THE approach to develop therapies for many (rare) inherited cardiac disorders including dilated and arrhythmogenic cardiomyopathy.
Consortium partners
Linked-in link: https://www.linkedin.com/showcase/geremy-eu
The mission of Netherlands Heart Institute is to develop new, excellent strategies for prevention, diagnosis and cure of cardiovascular disease by promoting cooperation between the cardiology departments of all university hospitals in the Netherlands.
The Netherlands Heart Institute encourages young, talented researchers and coaches them to the top.
The Netherlands Heart Institute fosters excellent cardiovascular research on national and international level. We conduct basic science as well as clinical research.
Visiting address
Moreelsepark 1
3511 EP Utrecht
The Netherlands
Tel. +31 (0)30 233 3600
P.O. Box address
Postbus 19258
3501 DG Utrecht, the Netherlands